Endoscopic polymer injection and endoluminal plication in treatment of gastroesophageal reflux disease: evaluation of long-term results

Carregando...
Imagem de Miniatura
Citações na Scopus
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
GEORG THIEME VERLAG KG
Citação
ENDOSCOPY INTERNATIONAL OPEN, v.6, n.5, p.E630-E636, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and study aims Us of proton pump inhibitors (PPIs) has made endoscopic treatment of gastroesophageal reflux disease (GERD) more efficient, with reduction in morbidity and complications. However, some patients persist with symptoms despite medical treatment and some are not compliant with it or cannot afford it for financial reasons, and thus they require non-pharmacological therapeutic options such as surgical fundoplication. Surgery may be effective in the short term, but there is related morbidity and concern about its long-term efficacy. The possibility of minimally invasive endoluminal surgeries has resulted in interest in and development of newly endoscopic devices. Good short-term results with surgical fundoplication lack of studies of is with long follow-up justify our interest in this study. The aim of this study was to investigate the efficacy of endoscopic polymer injection and endoluminal full-thickness plication in the long-term control of GERD. Patients and methods Forty-seven patients with GERD who underwent an endoscopic procedure were followed up for 60 months and evaluated for total response (RT), partial response (RP) and no response (SR) to endoscopic treatment with reintroduction of PPIs. Results Twenty-one patients received polymer injection (G0) and 26 endoluminal plication (G1). The number of patients with no response to endoscopic treatment with reintroduction of PPIs increased in time for both techniques (G0 P = 0.006; G1 P < 0.001). There was symptomatic improvement up to 12 months, with progressive loss of this trending up to 60 months in G0 and G1 (P < 0.001). Health-related quality of life score (GERD-HRQL) demonstrated TR in G0 and G1 at 1, 3, 6 and 12 months. The 60-month analysis showed an increased number of patients with SR in both groups. The quality of life assessment (SF-36) showed benefit in G0 up to 3 months. G0 showed a higher rate of complications. There were no deaths. There was healing of esophagitis at 3 months in 45 % of patients in G0 and 40 % in G1. There was no improvement in manometric or pH findings. Conclusion Endoscopic therapies were ineffective in controlling GERD in the long term.
Palavras-chave
Referências
  1. Antoniou SA, 2012, SURG ENDOSC, V26, P1063, DOI 10.1007/s00464-011-1999-0
  2. Bremner CG, 1997, AM J GASTROENTEROL, V92, P414
  3. Chen D, 2009, BRIT J SURG, V96, P128, DOI 10.1002/bjs.6440
  4. Chuttani R, 2003, GASTROINTEST ENDOSC, V58, P770, DOI 10.1016/S0016-5107(03)02027-3
  5. Dallemagne B, 1991, Surg Laparosc Endosc, V1, P138
  6. DEMEESTER TR, 1974, ANN SURG, V180, P511
  7. Deviere J, 2002, GASTROINTEST ENDOSC, V55, P335, DOI 10.1067/mge.2002.121596
  8. Domagk D, 2006, AM J GASTROENTEROL, V101, P422, DOI 10.1111/j.1572-0241.2006.00533
  9. El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269
  10. Fry LC, 2007, EUR J GASTROEN HEPAT, V19, P1125, DOI 10.1097/MEG.0b013e3282f16a21
  11. Higgins JPT, COCHRANE HDB SYSTEMA
  12. JAMIESON JR, 1992, AM J GASTROENTEROL, V87, P1102
  13. Kaindlstorfer A, 2013, SURG LAPARO ENDO PER, V23, P212, DOI 10.1097/SLE.0b013e3182827f79
  14. Lichtenstein DR, 2008, GASTROINTEST ENDOSC, V68, P815, DOI 10.1016/j.gie.2008.09.029
  15. Moraes JPP, 2004, BEST PRACT RES CL GA, V18, P23, DOI 10.1016/j.bpg.2004.06.008
  16. Niebisch Stefan, 2012, Curr Gastroenterol Rep, V14, P189, DOI 10.1007/s11894-012-0256-6
  17. NISSEN R, 1956, Schweiz Med Wochenschr, V86, P590
  18. Pinotti H W, 1980, Rev Hosp Clin Fac Med Sao Paulo, V35, P67
  19. Pleskow D, 2007, SURG ENDOSC, V21, P439, DOI 10.1007/s00464-006-9121-8
  20. Pleskow D, 2005, GASTROINTEST ENDOSC, V61, P643, DOI 10.1016/S0016-5107(04)02648-3
  21. Pleskow D, 2004, GASTROINTEST ENDOSC, V59, P163, DOI 10.1016/S0016-5107(03)02542-2
  22. Pleskow D, 2008, SURG ENDOSC, V22, P326, DOI 10.1007/s00464-007-9667-0
  23. Rothstein R, 2006, GASTROENTEROLOGY, V131, P704, DOI 10.1053/j.gastro.2006.07.004
  24. Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331
  25. Zilberstein B, 2005, DIS ESOPHAGUS, V18, P166, DOI 10.1111/j.1442-2050.2005.00494.x